These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4706478)

  • 1. Intraperitoneal noxytiolin as an experimental chemotherapeutic agent.
    Desai S; Jamieson CW
    Br J Surg; 1973 May; 60(5):350-1. PubMed ID: 4706478
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraperitoneal noxytiollin as an experimental chemotherapeutic agents.
    Desai S; Jamieson CW
    Br J Surg; 1973 Apr; 60(4):323. PubMed ID: 4700292
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of 1, 3-diallylurea and related compounds on growth of transplanted animal tumors.
    Tarnowski GS; Cappuccino JG; Schmid FA
    Cancer Res; 1967 Jun; 27(6):1092-5. PubMed ID: 5229785
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of bleomycin on the cell cycle of Ehrlich ascites carcinoma.
    Nagatsu M; Richart RM; Lambert A
    Cancer Res; 1972 Sep; 32(9):1966-70. PubMed ID: 4118376
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevention of Ehrlich ascites tumor using intraperitoneal colloidal 198Au. Dose vs. size of inoculum.
    Rogoff EE; Romano R; Hahn EW
    Radiology; 1975 Jan; 114(1):225-6. PubMed ID: 1208864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proceedings: Peritoneal implantation and resorption of Ehrlich ascites carcinoma from the abdominal cavity -- scanning electron microscopy].
    Richter IE; Wildenhof H; Remmele W
    Verh Dtsch Ges Pathol; 1974; 58():505. PubMed ID: 4460526
    [No Abstract]   [Full Text] [Related]  

  • 7. The antitumor action of bacterial extract. I. Suppression of mouse ascites tumors by the treatments with extracts of E. coli.
    Watanabe T
    Jpn J Exp Med; 1969 Dec; 39(6):631-47. PubMed ID: 4914751
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between subcutaneous and intraperitoneal transplants of the Ehrlich carcinoma; the possible role of anti-tumour antibody.
    Hallerbaker B; Hartveit F
    J Pathol; 1971 Oct; 105(2):95-103. PubMed ID: 5135342
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

  • 10. Hematogenous dissemination of tumour cells and metastases formation in Ehrlich ascites tumour.
    Kiseleva NS; Magamadov YC
    Neoplasma; 1972; 19(4):257-75. PubMed ID: 5054530
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
    Hartveit F; Halleraker B
    J Pathol; 1971 Oct; 105(2):85-93. PubMed ID: 5135341
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the growth of the Ehrlich ascites tumor in male and female mice.
    Vincent PC; Nicholls A
    Cancer Res; 1967 Jun; 27(6):1058-65. PubMed ID: 6027198
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of irradiation and chemotherapeutic agents on the capillaries of Ehrlich ascites carcinoma of mice.
    Egawa J; Ishioka K; Ogata T
    Acta Radiol Oncol Radiat Phys Biol; 1979; 18(6):535-43. PubMed ID: 94502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the effect of the tissue substance "cornin" on transplantable malignant tumors in mice.
    Ohya T
    Acta Med Okayama (1952); 1967 Oct; 21(5):227-50. PubMed ID: 4232096
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance to colchicine in a glycogen-containing subline of the Ehrlich-Lettré-ascites-tumour].
    Granzow C; Ehe-Galster U
    Z Krebsforsch; 1970; 74(4):329-37. PubMed ID: 4253580
    [No Abstract]   [Full Text] [Related]  

  • 17. The dual effect of cortisone on the growth of Ehrlich's ascites carcinoma.
    Hartveit F
    Br J Cancer; 1965 Sep; 19(3):594-8. PubMed ID: 5833078
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 19. Ratio of plasma glutaminases in liquid and solid tumour-bearing mice.
    Chakraborty P; Shirvastava GC
    Indian J Med Res; 1972 May; 60(5):800-7. PubMed ID: 4576305
    [No Abstract]   [Full Text] [Related]  

  • 20. IMMUNITY AND ANTIBODY FORMATION INDUCED BY INTRAPERITONEAL OR SUBCUTANEOUS INJECTION OF KREBS-2 ASCITES TUMOR CELLS TREATED WITH INFLUENZA VIRUS.
    EATON MD; LEVINTHAL JD; SCALA AR; JEWELL ML
    J Natl Cancer Inst; 1965 May; 34():661-72. PubMed ID: 14313824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.